Core Viewpoint - The document outlines the financial assistance management system of Zhejiang Zhaoli Pharmaceutical Co., Ltd., aiming to regulate external financial assistance, mitigate financial risks, and enhance corporate governance and internal control [1][2]. Summary by Sections General Principles - The system is established to standardize the company's external financial assistance behavior and prevent financial risks, based on relevant laws and regulations [1][2]. - External financial assistance refers to the company and its subsidiaries providing funds or loans, with exceptions for certain financing activities and assistance to majority-owned subsidiaries [2][3]. - The company must protect shareholders' rights and adhere to principles of equality, voluntariness, and fairness when providing financial assistance [3]. Approval Authority and Procedures - Financial assistance requires approval from the finance department and must be reviewed by the board of directors or shareholders' meeting [6]. - The board must approve financial assistance with a two-thirds majority of attending directors, excluding related directors from voting [6][7]. - Certain conditions, such as high asset-liability ratios or significant amounts of assistance, require additional shareholder meeting approval [7][8]. Information Disclosure - The company must disclose details of financial assistance, including the nature of the assistance, the recipient's information, risk prevention measures, and board opinions [7][8]. - If the recipient fails to repay or faces financial difficulties, the company must disclose the situation and any remedial measures taken [8][9]. Responsibilities and Division of Labor - The finance department and board office are responsible for assessing the recipient's financial health and ensuring compliance with approval procedures [9]. - The finance department monitors the recipient's performance and reports any issues to the board [9][10]. Penalties - Violations of the financial assistance regulations that result in losses or negative impacts on the company will lead to economic responsibility for the involved personnel, with severe cases being referred to judicial authorities [10]. Supplementary Provisions - The system will be implemented in accordance with national laws and the company's articles of association, with the board responsible for its formulation and revision [12].
佐力药业: 对外提供财务资助管理制度(2025年8月)